Application of Cell-Free DNA Analysis to Cancer Treatment

(Abstracted from N Engl J Med 2018;379(18):1754–1765) Tumor biopsies represent the standard for cancer diagnosis and the primary method for molecular testing to guide the selection of precision therapies. Liquid biopsies, particularly those involving cell-free DNA (cfDNA) from plasma, are rapidly emerging as an important and minimally invasive adjunct to standard tumor biopsies and, in some cases, even a potential alternative approach.
Source: Obstetrical and Gynecological Survey - Category: OBGYN Tags: OBSTETRICS: GENETICS Source Type: research